Western University of Health Sciences
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Western University of Health Sciences sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
Western University of Health Sciences: 16 sponsored US clinical trials, 2 recruiting.
Western University of Health Sciences sponsors 16 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 12 completed. 4 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cephalgia, with 1 trials.
Top-decile sponsor footprint
Western University of Health Sciences ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
16 total, page 1 of 1
ImmunoBoost: The Lymphatic Osteopathic Manipulative Treatment Protocol Study
NCT06565065
Tracking Post-stroke Walking Improvements From the Clinic Into the Home
NCT05454007
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
NCT05763940
The Cervical "STRETCH" Study
NCT07440030
Topical Absorption of Glutathione-cyclodextrin Complex in Healthy Human Subjects Improves Immune Response Against Mycobacterium Infection
NCT05926245
Outcomes of a Small Process Group on Medical Students' Grit, Resilience, and Stress
NCT06003920
Assessment of Three Basic Progressive Lens Designs
NCT05252871
Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps
NCT04928456
Entrainment Between Clinician and Patient During Palpation
NCT03579238
Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients
NCT03168841
Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy
NCT03174366
Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) in Individuals With Vertigo
NCT01529151
Effect of Osteopathic Manipulative Treatment for Patients With Chronic Headache
NCT01332864
Accommodation Disorders
NCT01329848
Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy
NCT00842023
Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight
NCT01335360
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
Where Western University of Health Sciences enrollment is open (later-stage tilt)
2 recruiting of 16 indexed (13% open); 12 completed (75%).
Phase mix: 4 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Cephalgia (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Western University of Health Sciences: open-pipeline peers nationwide
Peers matched on 16 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Western University of Health Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 trials (± recruiting share)
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
- Avidity Biosciences · 13% recruiting · 8 trials
Related
What to do with this Western University of Health Sciences page
16 registered trials is a research-attention snapshot, not an endorsement of Western University of Health Sciences or any single study.
- 2 of Western University of Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cephalgia is the condition Western University of Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cephalgia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Western University of Health Sciences pipeline card: 16 registered trials from official public datasets.Report a data error.